BioScrip Company Profile (NASDAQ:BIOS)

About BioScrip

BioScrip logoBioScrip, Inc. is engaged in providing infusion solutions. The Company partners with physicians, hospital systems, skilled nursing facilities, healthcare payors and pharmaceutical manufacturers to provide patients access to post-acute care services. The Company operates through Infusion Services segment. The Company operates through approximately 70 service locations in over 30 states. The Company offers home infusion services to provide clinical management services and the delivery of prescription medications. The Company provides services in coordination with, and under the direction of, the patient's physician. The Company's multidisciplinary team of clinicians, including pharmacists, nurses, dietitians and respiratory therapists, work with the physician to develop a plan of care suited to the patient's specific needs. Its platform provides service capabilities to deliver clinical management services that offer patients a community-based and home-based care environment.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Home Health Care
  • Sub-Industry: Health Care Services
  • Exchange: NASDAQ
  • Symbol: BIOS
  • CUSIP: 09069N10
Key Metrics:
  • Previous Close: $1.58
  • 50 Day Moving Average: $1.53
  • 200 Day Moving Average: $2.04
  • 52-Week Range: $117,682,000.00 - $0.98
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.75
  • P/E Growth: -0.33
  • Market Cap: $183.58M
  • Outstanding Shares: 117,682,000
  • Beta: 0.6
Profitability:
  • Net Margins: -5.18%
  • Return on Assets: -5.82%
Debt:
  • Debt-to-Equity Ratio: -15.98%
  • Current Ratio: 1.13%
  • Quick Ratio: 0.89%
Additional Links:
Companies Related to BioScrip:

Analyst Ratings

Consensus Ratings for BioScrip (NASDAQ:BIOS) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.50 (124.36% upside)

Analysts' Ratings History for BioScrip (NASDAQ:BIOS)
Show:
DateFirmActionRatingPrice TargetDetails
1/3/2017Lake Street CapitalInitiated CoverageBuy$4.50View Rating Details
11/8/2016Jefferies Group LLCInitiated CoverageBuy$2.50View Rating Details
3/5/2016StephensReiterated RatingBuyView Rating Details
8/12/2015Dougherty & CoLower Price TargetBuy$7.00 -> $4.00View Rating Details
8/11/2015SunTrust Banks, Inc.DowngradeBuy -> Neutral$5.00 -> $2.00View Rating Details
5/23/2015Barrington ResearchReiterated RatingOutperform$7.00 -> $6.00View Rating Details
4/9/2015Craig HallumInitiated CoverageBuy$7.00View Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for BioScrip (NASDAQ:BIOS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/3/2017ListenView Earnings Details
11/7/2016Q3($0.05)($0.12)$223.26 million$224.50 millionViewListenView Earnings Details
8/8/2016Q216($0.09)($0.14)$229.58 million$232.50 millionViewListenView Earnings Details
5/5/2016Q1($0.12)($0.17)$232.38 million$238.50 millionViewListenView Earnings Details
3/2/2016Q4($0.08)($0.13)$238.30 million$243.75 millionViewListenView Earnings Details
11/4/2015Q315($0.10)($0.38)$229.89 million$247.20 millionViewListenView Earnings Details
8/10/2015Q215($0.11)($3.60)$269.38 million$262.40 millionViewListenView Earnings Details
5/7/2015Q115($0.04)($0.17)$259.60 million$261.70 millionViewListenView Earnings Details
3/2/2015Q414$0.01($0.69)$259.62 million$253.70 millionViewListenView Earnings Details
11/5/2014Q314$0.02($0.42)$240.08 million$244.00 millionViewListenView Earnings Details
8/6/2014Q214($0.02)($0.01)$233.70 million$247.10 millionViewListenView Earnings Details
5/8/2014Q114($0.03)($0.13)$222.65 million$239.60 millionViewListenView Earnings Details
2/26/2014Q413$0.02$0.02$237.58 million$243.50 millionViewListenView Earnings Details
8/7/2013Q2 2013$0.04$0.13$206.47 million$190.73 millionViewListenView Earnings Details
5/8/2013Q1 2013$0.02$0.04$189.36 million$199.07 millionViewListenView Earnings Details
3/11/2013Q4 2012$0.01$0.04$173.87 million$180.70 millionViewListenView Earnings Details
11/7/2012Q312($0.01)($0.01)$159.86 million$170.36 millionViewN/AView Earnings Details
8/8/2012($0.01)($0.07)ViewN/AView Earnings Details
5/9/2012($0.01)($0.05)ViewN/AView Earnings Details
3/9/2012$0.09$0.12ViewN/AView Earnings Details
11/8/2011$0.09$0.10ViewN/AView Earnings Details
8/8/2011$0.08$0.10ViewN/AView Earnings Details
5/3/2011($0.01)$0.05ViewN/AView Earnings Details
3/11/2011$0.04($1.25)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioScrip (NASDAQ:BIOS)
Current Year EPS Consensus Estimate: $-0.39 EPS
Next Year EPS Consensus Estimate: $-0.16 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.07)($0.07)($0.07)
Q4 20163($0.11)$0.01($0.04)
Q1 20172($0.13)($0.08)($0.11)
Q2 20172($0.10)($0.06)($0.08)
Q3 20172($0.08)($0.04)($0.06)
Q4 20172($0.05)$0.00($0.03)
Q1 20181($0.10)($0.10)($0.10)
Q2 20181($0.07)($0.07)($0.07)
Q3 20181($0.06)($0.06)($0.06)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for BioScrip (NASDAQ:BIOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioScrip (NASDAQ:BIOS)
Insider Ownership Percentage: 2.30%
Institutional Ownership Percentage: 82.02%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/11/2016Jeffrey M KregerCFOBuy10,000$1.32$13,200.00View SEC Filing  
11/10/2016Daniel E GreenleafCEOBuy16,000$1.30$20,800.00View SEC Filing  
11/10/2016R Carter PateDirectorBuy20,000$1.30$26,000.00View SEC Filing  
6/22/2016Coliseum Capital Management, LDirectorBuy4,200,000$2.00$8,400,000.00View SEC Filing  
6/17/2016David W GoldingDirectorBuy12,500$2.48$31,000.00View SEC Filing  
8/24/2015Coliseum Capital Management, LDirectorBuy789,503$1.88$1,484,265.64View SEC Filing  
8/21/2015Coliseum Capital Management, LDirectorBuy632,907$1.81$1,145,561.67View SEC Filing  
8/18/2015David W GoldingDirectorBuy20,000$1.54$30,800.00View SEC Filing  
3/16/2015Richard M SmithCEOBuy5,000$4.27$21,350.00View SEC Filing  
3/12/2015Yon JordenDirectorBuy5,000$3.47$17,350.00View SEC Filing  
6/16/2014Myron Z HolubiakDirectorSell5,000$7.94$39,700.00View SEC Filing  
5/14/2014Yon JordenDirectorBuy5,000$7.21$36,050.00View SEC Filing  
8/30/2013Daniel ColucciVPSell18,500$12.40$229,400.00View SEC Filing  
8/28/2013David HubersDirectorSell11,200$12.23$136,976.00View SEC Filing  
8/28/2013Patricia BoguszVPSell39,687$11.94$473,862.78View SEC Filing  
8/19/2013Kohlberg Management V, LlcInsiderSell6,895,873$13.00$89,646,349.00View SEC Filing  
7/19/2013Myron Z HolubiakDirectorSell31,200$16.34$509,808.00View SEC Filing  
11/13/2012Stuart A SamuelsDirectorSell11,200$9.66$108,192.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioScrip (NASDAQ:BIOS)
DateHeadline
News IconWatching the Technicals: BioScrip Inc (BIOS) - The Standard (NASDAQ:BIOS)
6milestandard.com - February 24 at 3:52 PM
News IconA Look Ahead For 2 Stocks: Parker Drilling Company (PKD), BioScrip, Inc. (BIOS) - Post Analyst (NASDAQ:BIOS)
postanalyst.com - February 24 at 3:52 PM
News IconProminent Runners: Tahoe Resources Inc. (NYSE:TAHO), BioScrip, Inc. (NASDAQ:BIOS) - The Newburgh Press (NASDAQ:BIOS)
newburghpress.com - February 24 at 3:52 PM
News IconStock Update: Focusing on Shares of BioScrip, Inc. (NASDAQ:BIOS) - BVN (NASDAQ:BIOS)
bvnewsjournal.com - February 24 at 10:06 AM
News IconABR Of BioScrip, Inc. (NASDAQ:BIOS) Stock At 1.5 - Stock Observer (NASDAQ:BIOS)
www.thestockobserver.com - February 23 at 3:22 PM
News IconThe Technical Charts For BioScrip, Inc. (BIOS) Say It All Today - NY Stock News (NASDAQ:BIOS)
nystocknews.com - February 23 at 3:22 PM
News IconBioScrip, Inc. (NASDAQ:BIOS) Price Target At $2.187 - Transcript Daily (NASDAQ:BIOS)
transcriptdaily.com - February 23 at 3:22 PM
News IconFiscal Year Earnings Estimate on BioScrip, Inc.(BIOS) - Money Flow Index & Trends (NASDAQ:BIOS)
www.moneyflowtrends.com - February 23 at 3:22 PM
News IconBioScrip Inc BIOS Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300 (NASDAQ:BIOS)
www.bioportfolio.com - February 22 at 11:56 AM
News IconStock Price of BioScrip, Inc. (BIOS) Decreases -5.45% – Hignland ... - Highland Mirror (NASDAQ:BIOS)
www.highlandmirror.com - February 21 at 10:41 AM
News IconAre Insiders Buying This Stock? BioScrip, Inc. (NASDAQ:BIOS) Update - Winfield Review (NASDAQ:BIOS)
winfieldreview.com - February 20 at 10:54 AM
News IconBioScrip, Inc. (BIOS): How technical indicators have come out? - Post Analyst (NASDAQ:BIOS)
postanalyst.com - February 17 at 3:31 PM
News IconMovers to Watch For: BioScrip, Inc. (NASDAQ:BIOS), Celldex ... - The Newburgh Press (NASDAQ:BIOS)
newburghpress.com - February 16 at 5:32 AM
globenewswire.com logoBioScrip To Host Fourth Quarter and Full-Year 2016 Results Call - GlobeNewswire (press release) (NASDAQ:BIOS)
globenewswire.com - February 16 at 5:32 AM
finance.yahoo.com logoBioScrip To Host Fourth Quarter and Full-Year 2016 Results Call (NASDAQ:BIOS)
finance.yahoo.com - February 16 at 5:32 AM
News IconSignal Watch: Checking the Numbers for BioScrip Inc. (BIOS) - Rives Journal (NASDAQ:BIOS)
rivesjournal.com - February 13 at 9:25 PM
streetinsider.com logoForm 4 BioScrip, Inc. For: Feb 08 Filed by: Evans Dave - StreetInsider.com (NASDAQ:BIOS)
www.streetinsider.com - February 11 at 3:56 PM
News IconFollowing the Numbers for BioScrip, Inc. (NASDAQ:BIOS) - Benton Bulletin (NASDAQ:BIOS)
bentonbulletin.com - February 10 at 8:25 PM
News IconBioScrip, Inc. (NASDAQ:BIOS) Target Price At $2.187 - Transcript Daily (NASDAQ:BIOS)
transcriptdaily.com - February 10 at 3:24 PM
News IconForward Earnings Estimate of BioScrip, Inc.(BIOS) - Highland Mirror (NASDAQ:BIOS)
www.highlandmirror.com - February 10 at 3:24 PM
News IconBIOS – Bio Scrip Inc. - Men's News Daily (NASDAQ:BIOS)
mensnewsdaily.com - February 10 at 3:24 PM
realistinvestor.com logoThe Growth Forecast For BioScrip, Inc. (NASDAQ:BIOS) - RealistInvestor.com (NASDAQ:BIOS)
www.realistinvestor.com - February 7 at 4:52 PM
News IconWhat's Happening To These Stocks? – Schlumberger Limited (NYSE:SLB), BioScrip, Inc. (NASDAQ:BIOS) - Post Analyst (NASDAQ:BIOS)
postanalyst.com - February 7 at 4:52 PM
News IconBioScrip, Inc. (NASDAQ:BIOS) Institutional Ownership stands at 83.7 - The Newburgh Press (NASDAQ:BIOS)
newburghpress.com - February 7 at 4:52 PM
businesswire.com logoBioScrip, Inc. Joins Coalition to Advocate for Vulnerable Medicare Patients Losing Access to Home Infusion Care - Business Wire (press release) (NASDAQ:BIOS)
www.businesswire.com - February 7 at 4:52 PM
finance.yahoo.com logoBioScrip, Inc. Joins Coalition to Advocate for Vulnerable Medicare Patients Losing Access to Home Infusion Care (NASDAQ:BIOS)
finance.yahoo.com - February 6 at 8:56 PM
News IconFanning the Flames: Increased Volatility Noted on Shares of BioScrip, Inc. (NASDAQ:BIOS) - Davidson Register (NASDAQ:BIOS)
davidsonregister.com - February 6 at 3:56 PM
News IconStock Strength Analysis: BioScrip, Inc. (NASDAQ:BIOS) - The Oracle Examiner (NASDAQ:BIOS)
oracleexaminer.com - February 6 at 3:56 PM
realistinvestor.com logoBioScrip, Inc. (NASDAQ:BIOS) Mean Rating At $1.5 - Realist Investor - RealistInvestor.com (NASDAQ:BIOS)
www.realistinvestor.com - February 6 at 1:59 AM
News IconOutshines Stocks with Rosy Profitability: BioScrip, Inc. (NASDAQ:BIOS), Select Medical (NYSE:SEM) - Street Wise Report (press release) (blog) (NASDAQ:BIOS)
streetwisereport.com - February 5 at 3:54 PM
News IconEPS Forecast Of BioScrip, Inc. (NASDAQ:BIOS) Set At $-0.03 - Transcript Daily (NASDAQ:BIOS)
transcriptdaily.com - February 3 at 9:09 PM
News IconBioScrip, Inc. (NASDAQ:BIOS) Quarterly Analytical Analysis - The Newburgh Press (NASDAQ:BIOS)
newburghpress.com - February 3 at 9:09 PM
News IconWorth Watching Stock: Tempur Sealy International, Inc. (NYSE:TPX), BioScrip, Inc. (NASDAQ:BIOS) - The Newburgh Press (NASDAQ:BIOS)
newburghpress.com - February 3 at 2:07 AM
News IconBoom or Bust? Is there any value in BioScrip, Inc. (NASDAQ:BIOS) - Prospect Journal (NASDAQ:BIOS)
prospectjournal.com - January 30 at 8:47 PM
News IconAre Insiders Bumping Up Their Positions in BioScrip, Inc. (NASDAQ:BIOS) - Wall Street Beacon (NASDAQ:BIOS)
wsbeacon.com - January 30 at 8:47 PM
News IconIs This Stock Capable of a Bull Run: BioScrip, Inc. (NASDAQ:BIOS) - Nelson Research (NASDAQ:BIOS)
nelsonobserver.com - January 30 at 3:46 PM
realistinvestor.com logoMean Rating Of BioScrip, Inc. (NASDAQ:BIOS) At $1.5 - RealistInvestor.com (NASDAQ:BIOS)
www.realistinvestor.com - January 30 at 3:46 PM
News IconAre There Any Catalysts to Propel Shares of BioScrip, Inc. (NASDAQ:BIOS) - Prospect Journal (NASDAQ:BIOS)
prospectjournal.com - January 30 at 3:46 PM
News IconBioScrip, Inc. (NASDAQ:BIOS) Projected EPS At $-0.08 - Stock Observer (NASDAQ:BIOS)
www.thestockobserver.com - January 30 at 3:46 PM
News IconBioScrip, Inc. (NASDAQ:BIOS) Long-Term Growth Estimate At $14.1667 - Transcript Daily (NASDAQ:BIOS)
transcriptdaily.com - January 30 at 3:46 PM
News IconPrice Target Of BioScrip, Inc. (NASDAQ:BIOS)At $2.187 - Transcript Daily (NASDAQ:BIOS)
transcriptdaily.com - January 29 at 1:55 AM
seekingalpha.com logoBioScrip, Inc. (BIOS) (NASDAQ:BIOS)
seekingalpha.com - January 28 at 2:09 AM
News IconBargain or Bait? Stock Update on BioScrip, Inc. (NASDAQ:BIOS ... - Prospect Journal (NASDAQ:BIOS)
prospectjournal.com - January 27 at 3:57 PM
News IconGrowth Analysis of BioScrip, Inc. (NASDAQ:BIOS) | Newburgh Press - The Newburgh Press (NASDAQ:BIOS)
newburghpress.com - January 26 at 4:34 PM
News IconConsensus Price Of BioScrip, Inc. (NASDAQ:BIOS) Set At $2.187 - Transcript Daily (NASDAQ:BIOS)
transcriptdaily.com - January 26 at 4:34 PM
News IconStock Seesawing as Volatility Sweeps in on BioScrip, Inc. (NASDAQ:BIOS) - Wall Street Beacon (NASDAQ:BIOS)
wsbeacon.com - January 26 at 4:33 PM
News IconBioScrip, Inc. (NASDAQ:BIOS) has 1 Year Target Estimate of $2.5 - The Newburgh Press (NASDAQ:BIOS)
newburghpress.com - January 26 at 4:33 PM
biz.yahoo.com logoBIOSCRIP, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:BIOS)
biz.yahoo.com - January 26 at 4:33 PM
istreetwire.com logo3 Stocks in Focus: Baker Hughes Incorporated (BHI), BioScrip, Inc. (BIOS), McDermott International, Inc. (MDR) - iStreetWire (NASDAQ:BIOS)
istreetwire.com - January 25 at 2:27 AM
News IconBioScrip, Inc. (NASDAQ:BIOS) Stock ABR At 1.5 - Stock Observer (NASDAQ:BIOS)
www.thestockobserver.com - January 25 at 2:27 AM

Social

What is BioScrip's stock symbol?

BioScrip trades on the NASDAQ under the ticker symbol "BIOS."

Where is BioScrip's stock going? Where will BioScrip's stock price be in 2017?

3 brokers have issued 1-year price targets for BioScrip's shares. Their forecasts range from $2.50 to $4.50. On average, they expect BioScrip's stock price to reach $3.50 in the next twelve months.

When will BioScrip announce their earnings?

BioScrip is scheduled to release their next quarterly earnings announcement on Tuesday, February, 28th 2017.

Who owns BioScrip stock?

BioScrip's stock is owned by a variety of of retail and institutional investors. Top institutional investors include GAMCO INVESTORS, INC. ET AL Total Shares: 16,785,012 (14.26%), Gabelli Funds LLC (12.75%), Wynnefield Capital Inc. (3.14%), FMR LLC (3.00%), Deerfield Management Co. (1.68%) and Dimensional Fund Advisors LP (1.36%). Company insiders that own BioScrip stock include Coliseum Capital Management, L, Daniel E Greenleaf, David W Golding, Jeffrey M Kreger, R Carter Pate, Richard M Smith and Yon Jorden.

Who sold BioScrip stock? Who is selling BioScrip stock?

BioScrip's stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Menta Capital LLC and Formidable Asset Management LLC.

Who bought BioScrip stock? Who is buying BioScrip stock?

BioScrip's stock was purchased by a variety of institutional investors in the last quarter, including Wynnefield Capital Inc., FMR LLC, Gabelli Funds LLC, Gamco Investors INC. ET AL, State Street Corp and Teton Advisors Inc.. Company insiders that have bought BioScrip stock in the last two years include Coliseum Capital Management, L, Daniel E Greenleaf, David W Golding, Jeffrey M Kreger, R Carter Pate, Richard M Smith and Yon Jorden.

How do I buy BioScrip stock?

Shares of BioScrip can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of BioScrip stock cost?

One share of BioScrip stock can currently be purchased for approximately $1.56.

BioScrip (NASDAQ:BIOS) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for BioScrip (NASDAQ:BIOS)

Earnings History Chart

Earnings by Quarter for BioScrip (NASDAQ:BIOS)

Dividend History Chart

Dividend Payments by Quarter for BioScrip (NASDAQ:BIOS)

Last Updated on 2/27/2017 by MarketBeat.com Staff